arrow
A

Alen Ostojić

national institutes of health
H指数:10
被引数:346

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baricitinib for refractory chronic graft-versus-host-disease: Results of a phase 1/2 study.

巴瑞替尼治疗难治性慢性移植物抗宿主病:一项1/2期研究的结果

2026-05-280
OAAI
Real-world disease characteristics and frontline treatments used in chronic lymphocytic leukaemia in Bulgaria: An observational cohort study (DESCRIBE)

保加利亚慢性淋巴细胞白血病的真实世界疾病特征和一线治疗方案:一项观察性队列研究(DESCRIBE)

2026-02-010
PRE
Phase 1/2 study of high-dose palifermin for GVHD prophylaxis in patients undergoing HLA-matched unrelated donor HCT

I期/II期高剂量palifermin用于HLA匹配无关供者HCT患者GVHD预防的研究

Blood
IF23.1
2025-05-090
PRE
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
2024-08-151
OAAI